Review



mouse anti-glua2-n-terminus antibody (#mab397)  (Millipore)


Bioz Verified Symbol Millipore is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Millipore mouse anti-glua2-n-terminus antibody (#mab397)
    ( A , B ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( A ) and <t>GluA2</t> ( B ) from WT primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, * P = 0.0192 for surface level, P = 0.42 for total level, and n = 17 and 18 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, ** P = 0.0025 for surface level, P = 0.1584 for total level, and n = 16 and 20 cells from two independent cultures treated with Scr and Aβ42, respectively. ( C , D ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( C ) and GluA2 ( D ) from PSD-95 +/− primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, P = 0.4539 for surface level, P = 0.1311 for total level, and n = 14 and 13 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, P = 0.6643 for surface level, P = 0.659 for total level, and n = 13 and 14 cells from two independent cultures treated with Scr and Aβ42, respectively. Data Information: significance was determined by Student’s t test ( A , C ) or Mann–Whitney U test ( B , D ). Data are represented as mean ± SEM with * P < 0.05, ** P < 0.01, ns non-significant. Scale bar: 5 μm. .
    Mouse Anti Glua2 N Terminus Antibody (#Mab397), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-glua2+n+terminus/glua1+antibody/pmc10933348-259-5-11
    Average 90 stars, based on 1 article reviews
    mouse anti-glua2-n-terminus antibody (#mab397) - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Hyperfunction of post-synaptic density protein 95 promotes seizure response in early-stage aβ pathology"

    Article Title: Hyperfunction of post-synaptic density protein 95 promotes seizure response in early-stage aβ pathology

    Journal: EMBO Reports

    doi: 10.1038/s44319-024-00090-0

    ( A , B ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( A ) and GluA2 ( B ) from WT primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, * P = 0.0192 for surface level, P = 0.42 for total level, and n = 17 and 18 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, ** P = 0.0025 for surface level, P = 0.1584 for total level, and n = 16 and 20 cells from two independent cultures treated with Scr and Aβ42, respectively. ( C , D ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( C ) and GluA2 ( D ) from PSD-95 +/− primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, P = 0.4539 for surface level, P = 0.1311 for total level, and n = 14 and 13 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, P = 0.6643 for surface level, P = 0.659 for total level, and n = 13 and 14 cells from two independent cultures treated with Scr and Aβ42, respectively. Data Information: significance was determined by Student’s t test ( A , C ) or Mann–Whitney U test ( B , D ). Data are represented as mean ± SEM with * P < 0.05, ** P < 0.01, ns non-significant. Scale bar: 5 μm. .
    Figure Legend Snippet: ( A , B ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( A ) and GluA2 ( B ) from WT primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, * P = 0.0192 for surface level, P = 0.42 for total level, and n = 17 and 18 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, ** P = 0.0025 for surface level, P = 0.1584 for total level, and n = 16 and 20 cells from two independent cultures treated with Scr and Aβ42, respectively. ( C , D ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( C ) and GluA2 ( D ) from PSD-95 +/− primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, P = 0.4539 for surface level, P = 0.1311 for total level, and n = 14 and 13 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, P = 0.6643 for surface level, P = 0.659 for total level, and n = 13 and 14 cells from two independent cultures treated with Scr and Aβ42, respectively. Data Information: significance was determined by Student’s t test ( A , C ) or Mann–Whitney U test ( B , D ). Data are represented as mean ± SEM with * P < 0.05, ** P < 0.01, ns non-significant. Scale bar: 5 μm. .

    Techniques Used: Immunocytochemistry, Marker, MANN-WHITNEY

    Related Articles

    Recombinant:

    Article Title:
    Article Snippet: The following commercial antibodies and reagents were used in this study: RIPK1 (Cell Signaling Technology, #3493); p-S166 RIPK1 (Biolynx Company, BX60008, mouse specific); MeCP2 (Cell Signaling Technology, #3456); β-actin (TransGen Biotech HC201); A20 (Cell Signaling Technology, #5630); Nox2 (ThermoFisher, PA5-76034); Nox1 (ThermoFisher, PA5-76034); SLC7A11 (Cell Signaling Technology, #12691); Mfn2 (Cell Signaling Technology, #11925); Drp1 (Cell Signaling Technology, #8570); p-S616 Drp1 (Cell Signaling Technology, #4494); PERK (Cell Signaling Technology, #3192); IRE1α (Cell Signaling Technology, #3294); ATF6 (Cell Signaling Technology, #65880); BiP (Abcam, ab21685); p-S51 eIF2α (Cell Signaling Technology, #3398); eIF2α (Cell Signaling Technology, #5324); VGLUT1 (Cell Signaling Technology, #47181); SNAT1 (Cell Signaling Technology, #36057); GLS1 (Cell Signaling Technology, #36057); GluA1 (Sigma-Aldrich, SAB5201086); GluA2/3 (MilliporeSigma, AB1506); anti-rabbit (SouthernBiotech, #4050-05); Iba1 (FUJIFILM, #019-19741); Iba1 (FUJIFILM, #011-27991); CD68 (Bio-Rad, MCA1957); mouseCD11b-APC (BioLegend, #101212); mouseCD45-488 (BioLegend, #103122); DAPI (ThermoFisher, D1306); anti-mouse (Southern Biotech, #1031-05); Recombinant hTNFα (Novoprotein, #C008); 5Z7-Oxozeaenol (Sigma-Aldrich, #O9890); zVAD.fmk (MedChemExpress, HY-16658); Cycloheximide (MCE, HY-12320); SM-164 (MedChemExpress, HY-15989); CellROXTM Orange (ThermoFisher, C10443); Thapsigargin (MedChemExpress, HY-13433); Brefeldin A (MedChemExpress, HY16592); Diphenyleneiodonium chloride (MedChemExpress, HY-100965); 6-Diazo-5-oxo-L-norLeucine (MedChemExpress, HY-108357); BPTES (HY-12683); VAS2870 (MCE, HY-12804); Lucigenin (MCE, HY-D0720); Mito-TrackerTM Red (ThermoFisher, M22425); ER-Tracker Red (ThermoFisher, E34251).

    Article Title: Radixin in the nucleus accumbens core modulates amphetamine-induced locomotor activity based on context association.
    Article Snippet: A hallmark of drug addiction is pathological craving, or an urge for drugs of abuse (Cheron and Kerchove d’Exaerde 2021; Tiffany and Wray 2012), which increases the risk of relapse in people with substance use disorders (SUD) (Jaffe et al. 1989; Preston et al. 1993).. In rats, repeated exposure to psychostimulants, such as amphetamine (AMPH), leads to behavioral sensitization, manifested as an enhanced increase in locomotor activity when subsequently challenged with the drug following a withdrawal period.. Behavioral sensitization is largely mediated by increased dopamine transmission in the mesolimbic dopamine system, and has been proposed as an animal model that reflects characteristics observed in people with SUD, such as escalation of drug use and long-lasting craving (Boileau et al. 2006; Robinson and Berridge 1993; Vezina 2004).

    Article Title: Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling
    Article Snippet: The primary antibodies included MAP2 (Millipore, Cat# AB5622-1, 1:300), PSD95 (Synaptic Systems, Cat# 124014, 1:300), GluA1-C (Millipore, Cat# AB1504, 1:200), GluA2-C (NeuroMab, SKU: 75-002, 1:200), EEA1 (Cell Signaling, Cat# 2411, 1:100), Rab4 (Cell Signaling, Cat# 2167, 1:50), Rab4 (Santa Cruz, Cat# sc-517263, 1:50), and Rab11 (Cell Signaling, Cat# 5589, 1:50), and Rab11 (ThermoFisher, Cat# MA5-49197, 1:50).

    Article Title: A toolbox for ablating excitatory and inhibitory synapses
    Article Snippet: Primary antibody concentrations used: mouse anti- PSD- 95 (1:3000, Novus Biological, cat. # NB300- 556), rabbit anti- GluA1 (1:1000, Millipore Sigma, ABN241), and chicken anti- GFP (1:10,000, Aves Labs, cat. # NC9510598), Rabbit anti- HA (1:1000, Cell Signaling, cat. # 3724), chicken anti myc (1:1000, Novus Biologicals cat. # NB600- 334).

    Article Title: Combinatorial transcriptional regulation establishes subtype-appropriate synaptic properties in auditory neurons.
    Article Snippet: Cochlear turns were stained overnight with anti-Calb2 (1:1000, Swant CG1), anti-CTBP2 (1:500, BD Transduction Laboratories, Clone 16) and anti-GluA2 (1:500, EMB Millipore MAB 397) and subsequently with corresponding secondaries at 37◦C overnight.

    Article Title: Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance.
    Article Snippet: The antibodies used were anti-rabbit p845 GluA1 antibody (ab109464), anti-rabbit GluA2 (ab133477), and anti-rabbit PSD95 (ab18258) obtained from Abcam; anti-rabbit GluA1 (ab1505) from Millipore; and antimouse tubulin (T5201) from Sigma.

    Article Title: Gating and noelin clustering of native Ca 2+ -permeable AMPA receptors.
    Article Snippet: This is a PDF file of a peer-reviewed paper that has been accepted for publication.. Although unedited, the content has been subjected to preliminary formatting.. Nature is providing this early version of the typeset paper as a service to our authors and readers.

    Article Title: A toolbox for ablating excitatory and inhibitory synapses
    Article Snippet: Antibody , Anti-GluA1 (rabbit polyclonal) , Commercially available. , Millipore Sigma cat. # ABN241 , 1:1000.

    Plasmid Preparation:

    Article Title:
    Article Snippet: The following commercial antibodies and reagents were used in this study: RIPK1 (Cell Signaling Technology, #3493); p-S166 RIPK1 (Biolynx Company, BX60008, mouse specific); MeCP2 (Cell Signaling Technology, #3456); β-actin (TransGen Biotech HC201); A20 (Cell Signaling Technology, #5630); Nox2 (ThermoFisher, PA5-76034); Nox1 (ThermoFisher, PA5-76034); SLC7A11 (Cell Signaling Technology, #12691); Mfn2 (Cell Signaling Technology, #11925); Drp1 (Cell Signaling Technology, #8570); p-S616 Drp1 (Cell Signaling Technology, #4494); PERK (Cell Signaling Technology, #3192); IRE1α (Cell Signaling Technology, #3294); ATF6 (Cell Signaling Technology, #65880); BiP (Abcam, ab21685); p-S51 eIF2α (Cell Signaling Technology, #3398); eIF2α (Cell Signaling Technology, #5324); VGLUT1 (Cell Signaling Technology, #47181); SNAT1 (Cell Signaling Technology, #36057); GLS1 (Cell Signaling Technology, #36057); GluA1 (Sigma-Aldrich, SAB5201086); GluA2/3 (MilliporeSigma, AB1506); anti-rabbit (SouthernBiotech, #4050-05); Iba1 (FUJIFILM, #019-19741); Iba1 (FUJIFILM, #011-27991); CD68 (Bio-Rad, MCA1957); mouseCD11b-APC (BioLegend, #101212); mouseCD45-488 (BioLegend, #103122); DAPI (ThermoFisher, D1306); anti-mouse (Southern Biotech, #1031-05); Recombinant hTNFα (Novoprotein, #C008); 5Z7-Oxozeaenol (Sigma-Aldrich, #O9890); zVAD.fmk (MedChemExpress, HY-16658); Cycloheximide (MCE, HY-12320); SM-164 (MedChemExpress, HY-15989); CellROXTM Orange (ThermoFisher, C10443); Thapsigargin (MedChemExpress, HY-13433); Brefeldin A (MedChemExpress, HY16592); Diphenyleneiodonium chloride (MedChemExpress, HY-100965); 6-Diazo-5-oxo-L-norLeucine (MedChemExpress, HY-108357); BPTES (HY-12683); VAS2870 (MCE, HY-12804); Lucigenin (MCE, HY-D0720); Mito-TrackerTM Red (ThermoFisher, M22425); ER-Tracker Red (ThermoFisher, E34251).

    Article Title: Radixin in the nucleus accumbens core modulates amphetamine-induced locomotor activity based on context association.
    Article Snippet: A hallmark of drug addiction is pathological craving, or an urge for drugs of abuse (Cheron and Kerchove d’Exaerde 2021; Tiffany and Wray 2012), which increases the risk of relapse in people with substance use disorders (SUD) (Jaffe et al. 1989; Preston et al. 1993).. In rats, repeated exposure to psychostimulants, such as amphetamine (AMPH), leads to behavioral sensitization, manifested as an enhanced increase in locomotor activity when subsequently challenged with the drug following a withdrawal period.. Behavioral sensitization is largely mediated by increased dopamine transmission in the mesolimbic dopamine system, and has been proposed as an animal model that reflects characteristics observed in people with SUD, such as escalation of drug use and long-lasting craving (Boileau et al. 2006; Robinson and Berridge 1993; Vezina 2004).

    Article Title: Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling
    Article Snippet: The primary antibodies included MAP2 (Millipore, Cat# AB5622-1, 1:300), PSD95 (Synaptic Systems, Cat# 124014, 1:300), GluA1-C (Millipore, Cat# AB1504, 1:200), GluA2-C (NeuroMab, SKU: 75-002, 1:200), EEA1 (Cell Signaling, Cat# 2411, 1:100), Rab4 (Cell Signaling, Cat# 2167, 1:50), Rab4 (Santa Cruz, Cat# sc-517263, 1:50), and Rab11 (Cell Signaling, Cat# 5589, 1:50), and Rab11 (ThermoFisher, Cat# MA5-49197, 1:50).

    Article Title: A toolbox for ablating excitatory and inhibitory synapses
    Article Snippet: Primary antibody concentrations used: mouse anti- PSD- 95 (1:3000, Novus Biological, cat. # NB300- 556), rabbit anti- GluA1 (1:1000, Millipore Sigma, ABN241), and chicken anti- GFP (1:10,000, Aves Labs, cat. # NC9510598), Rabbit anti- HA (1:1000, Cell Signaling, cat. # 3724), chicken anti myc (1:1000, Novus Biologicals cat. # NB600- 334).

    Article Title: Combinatorial transcriptional regulation establishes subtype-appropriate synaptic properties in auditory neurons.
    Article Snippet: Cochlear turns were stained overnight with anti-Calb2 (1:1000, Swant CG1), anti-CTBP2 (1:500, BD Transduction Laboratories, Clone 16) and anti-GluA2 (1:500, EMB Millipore MAB 397) and subsequently with corresponding secondaries at 37◦C overnight.

    Article Title: Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance.
    Article Snippet: The antibodies used were anti-rabbit p845 GluA1 antibody (ab109464), anti-rabbit GluA2 (ab133477), and anti-rabbit PSD95 (ab18258) obtained from Abcam; anti-rabbit GluA1 (ab1505) from Millipore; and antimouse tubulin (T5201) from Sigma.

    Article Title: Gating and noelin clustering of native Ca 2+ -permeable AMPA receptors.
    Article Snippet: This is a PDF file of a peer-reviewed paper that has been accepted for publication.. Although unedited, the content has been subjected to preliminary formatting.. Nature is providing this early version of the typeset paper as a service to our authors and readers.

    Article Title: A toolbox for ablating excitatory and inhibitory synapses
    Article Snippet: Antibody , Anti-GluA1 (rabbit polyclonal) , Commercially available. , Millipore Sigma cat. # ABN241 , 1:1000.

    Control:

    Article Title:
    Article Snippet: The following commercial antibodies and reagents were used in this study: RIPK1 (Cell Signaling Technology, #3493); p-S166 RIPK1 (Biolynx Company, BX60008, mouse specific); MeCP2 (Cell Signaling Technology, #3456); β-actin (TransGen Biotech HC201); A20 (Cell Signaling Technology, #5630); Nox2 (ThermoFisher, PA5-76034); Nox1 (ThermoFisher, PA5-76034); SLC7A11 (Cell Signaling Technology, #12691); Mfn2 (Cell Signaling Technology, #11925); Drp1 (Cell Signaling Technology, #8570); p-S616 Drp1 (Cell Signaling Technology, #4494); PERK (Cell Signaling Technology, #3192); IRE1α (Cell Signaling Technology, #3294); ATF6 (Cell Signaling Technology, #65880); BiP (Abcam, ab21685); p-S51 eIF2α (Cell Signaling Technology, #3398); eIF2α (Cell Signaling Technology, #5324); VGLUT1 (Cell Signaling Technology, #47181); SNAT1 (Cell Signaling Technology, #36057); GLS1 (Cell Signaling Technology, #36057); GluA1 (Sigma-Aldrich, SAB5201086); GluA2/3 (MilliporeSigma, AB1506); anti-rabbit (SouthernBiotech, #4050-05); Iba1 (FUJIFILM, #019-19741); Iba1 (FUJIFILM, #011-27991); CD68 (Bio-Rad, MCA1957); mouseCD11b-APC (BioLegend, #101212); mouseCD45-488 (BioLegend, #103122); DAPI (ThermoFisher, D1306); anti-mouse (Southern Biotech, #1031-05); Recombinant hTNFα (Novoprotein, #C008); 5Z7-Oxozeaenol (Sigma-Aldrich, #O9890); zVAD.fmk (MedChemExpress, HY-16658); Cycloheximide (MCE, HY-12320); SM-164 (MedChemExpress, HY-15989); CellROXTM Orange (ThermoFisher, C10443); Thapsigargin (MedChemExpress, HY-13433); Brefeldin A (MedChemExpress, HY16592); Diphenyleneiodonium chloride (MedChemExpress, HY-100965); 6-Diazo-5-oxo-L-norLeucine (MedChemExpress, HY-108357); BPTES (HY-12683); VAS2870 (MCE, HY-12804); Lucigenin (MCE, HY-D0720); Mito-TrackerTM Red (ThermoFisher, M22425); ER-Tracker Red (ThermoFisher, E34251).

    Article Title: Radixin in the nucleus accumbens core modulates amphetamine-induced locomotor activity based on context association.
    Article Snippet: A hallmark of drug addiction is pathological craving, or an urge for drugs of abuse (Cheron and Kerchove d’Exaerde 2021; Tiffany and Wray 2012), which increases the risk of relapse in people with substance use disorders (SUD) (Jaffe et al. 1989; Preston et al. 1993).. In rats, repeated exposure to psychostimulants, such as amphetamine (AMPH), leads to behavioral sensitization, manifested as an enhanced increase in locomotor activity when subsequently challenged with the drug following a withdrawal period.. Behavioral sensitization is largely mediated by increased dopamine transmission in the mesolimbic dopamine system, and has been proposed as an animal model that reflects characteristics observed in people with SUD, such as escalation of drug use and long-lasting craving (Boileau et al. 2006; Robinson and Berridge 1993; Vezina 2004).

    Article Title: Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling
    Article Snippet: The primary antibodies included MAP2 (Millipore, Cat# AB5622-1, 1:300), PSD95 (Synaptic Systems, Cat# 124014, 1:300), GluA1-C (Millipore, Cat# AB1504, 1:200), GluA2-C (NeuroMab, SKU: 75-002, 1:200), EEA1 (Cell Signaling, Cat# 2411, 1:100), Rab4 (Cell Signaling, Cat# 2167, 1:50), Rab4 (Santa Cruz, Cat# sc-517263, 1:50), and Rab11 (Cell Signaling, Cat# 5589, 1:50), and Rab11 (ThermoFisher, Cat# MA5-49197, 1:50).

    Article Title: A toolbox for ablating excitatory and inhibitory synapses
    Article Snippet: Primary antibody concentrations used: mouse anti- PSD- 95 (1:3000, Novus Biological, cat. # NB300- 556), rabbit anti- GluA1 (1:1000, Millipore Sigma, ABN241), and chicken anti- GFP (1:10,000, Aves Labs, cat. # NC9510598), Rabbit anti- HA (1:1000, Cell Signaling, cat. # 3724), chicken anti myc (1:1000, Novus Biologicals cat. # NB600- 334).

    Article Title: Combinatorial transcriptional regulation establishes subtype-appropriate synaptic properties in auditory neurons.
    Article Snippet: Cochlear turns were stained overnight with anti-Calb2 (1:1000, Swant CG1), anti-CTBP2 (1:500, BD Transduction Laboratories, Clone 16) and anti-GluA2 (1:500, EMB Millipore MAB 397) and subsequently with corresponding secondaries at 37◦C overnight.

    Article Title: Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance.
    Article Snippet: The antibodies used were anti-rabbit p845 GluA1 antibody (ab109464), anti-rabbit GluA2 (ab133477), and anti-rabbit PSD95 (ab18258) obtained from Abcam; anti-rabbit GluA1 (ab1505) from Millipore; and antimouse tubulin (T5201) from Sigma.

    Article Title: Gating and noelin clustering of native Ca 2+ -permeable AMPA receptors.
    Article Snippet: This is a PDF file of a peer-reviewed paper that has been accepted for publication.. Although unedited, the content has been subjected to preliminary formatting.. Nature is providing this early version of the typeset paper as a service to our authors and readers.

    Article Title: A toolbox for ablating excitatory and inhibitory synapses
    Article Snippet: Antibody , Anti-GluA1 (rabbit polyclonal) , Commercially available. , Millipore Sigma cat. # ABN241 , 1:1000.



    Similar Products

    mouse anti-glua2-n-terminus antibody (#mab397)  (Millipore)
    90
    Millipore mouse anti-glua2-n-terminus antibody (#mab397)
    ( A , B ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( A ) and <t>GluA2</t> ( B ) from WT primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, * P = 0.0192 for surface level, P = 0.42 for total level, and n = 17 and 18 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, ** P = 0.0025 for surface level, P = 0.1584 for total level, and n = 16 and 20 cells from two independent cultures treated with Scr and Aβ42, respectively. ( C , D ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( C ) and GluA2 ( D ) from PSD-95 +/− primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, P = 0.4539 for surface level, P = 0.1311 for total level, and n = 14 and 13 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, P = 0.6643 for surface level, P = 0.659 for total level, and n = 13 and 14 cells from two independent cultures treated with Scr and Aβ42, respectively. Data Information: significance was determined by Student’s t test ( A , C ) or Mann–Whitney U test ( B , D ). Data are represented as mean ± SEM with * P < 0.05, ** P < 0.01, ns non-significant. Scale bar: 5 μm. .
    Mouse Anti Glua2 N Terminus Antibody (#Mab397), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-glua2+n+terminus/glua1+antibody/pmc10933348-259-5-11
    Average 90 stars, based on 1 article reviews
    mouse anti-glua2-n-terminus antibody (#mab397) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    anti-glua2 n terminus  (Millipore)
    90
    Millipore anti-glua2 n terminus
    ODN2088 blocks NMDA-induced internalization of <t>GluA2</t> containing AMPA receptors. A , immunocytochemical analysis of the effects of ODN2088 on the NMDA-induced reduction of cell surface GluA2. Cultured hippocampal neurons expressing hemagglutinin (HA)-tagged GluA2 were treated with 50 μM NMDA for 10 min without or with ODN2088 (1 μM, 10 min). After fixation, cell surface HA-GluA2 were stained ( red ) and after treatment with Triton X-100, neurons were immunostained for total HA-GluA2 ( blue ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced reduction in the ratio of surface to total HA-GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity to total HA-GluA2 immunoreactivity. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 22). Data are presented as mean + SEMs and individual data points. p value by one-way ANOVA, followed by Student-Newman-Keuls post hoc test. B and C , antibody-feeding assay evaluating the effects of ODN2088 on NMDA-induced internalization of cell surface HA-GluA2 ( B ) and endogenous GluA2 ( C ). B , living neurons expressing exogenous HA-GluA2 were labeled with anti-HA antibodies. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface HA antibodies were stained ( red ), and after treatment with Triton X-100, internalized HA antibodies were stained ( green ). The dendritic regions marked by squares are magnified in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface HA-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 14). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student−Newman−Keuls post hoc test. C , endogenous GluA2 in living neurons was labeled with antibodies against the extracellular region of GluA2. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface GluA2 antibodies were stained ( red ), and after treatment with Triton X-100, internalized GluA2 antibodies ( green ) and the dendritic marker MAP2 were stained ( blue/white ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface GluA2-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 11–13). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student-Newman-Keuls post hoc test. D , biotinylation assay of endogenous GluA2. Hippocampal cultures were stimulated by NMDA without or with ODN2088. Cell surface proteins were biotinylated and pulled down from the total cell lysates. The amount of GluA2 proteins in the pulled down fraction ( left gel ) and total cell lysate fraction ( right gel ) were analyzed with the immunoblot analysis. NMDA stimulation decreased the amount of the cell surface GluA2, and treatment with ODN2088 blocked the NMDA effect. Right graph : the intensity of the GluA2 band in the biotinylated fraction was normalized to that of the total cell lysate fraction. The ratio of biotinylated/total GluA2 in the control cultures without ODN2088 treatment was arbitrarily set to 100% (n = 4 each). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Student-Newman-Keuls post hoc test. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; NMDA, N-methyl-d-aspartate.
    Anti Glua2 N Terminus, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-glua2+n+terminus/glua1+antibody/pmc10943477-360-8-11
    Average 90 stars, based on 1 article reviews
    anti-glua2 n terminus - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    glua2 (n-terminus) alomone agp-073  (Alomone Labs)
    93
    Alomone Labs glua2 (n-terminus) alomone agp-073
    ODN2088 blocks NMDA-induced internalization of <t>GluA2</t> containing AMPA receptors. A , immunocytochemical analysis of the effects of ODN2088 on the NMDA-induced reduction of cell surface GluA2. Cultured hippocampal neurons expressing hemagglutinin (HA)-tagged GluA2 were treated with 50 μM NMDA for 10 min without or with ODN2088 (1 μM, 10 min). After fixation, cell surface HA-GluA2 were stained ( red ) and after treatment with Triton X-100, neurons were immunostained for total HA-GluA2 ( blue ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced reduction in the ratio of surface to total HA-GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity to total HA-GluA2 immunoreactivity. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 22). Data are presented as mean + SEMs and individual data points. p value by one-way ANOVA, followed by Student-Newman-Keuls post hoc test. B and C , antibody-feeding assay evaluating the effects of ODN2088 on NMDA-induced internalization of cell surface HA-GluA2 ( B ) and endogenous GluA2 ( C ). B , living neurons expressing exogenous HA-GluA2 were labeled with anti-HA antibodies. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface HA antibodies were stained ( red ), and after treatment with Triton X-100, internalized HA antibodies were stained ( green ). The dendritic regions marked by squares are magnified in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface HA-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 14). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student−Newman−Keuls post hoc test. C , endogenous GluA2 in living neurons was labeled with antibodies against the extracellular region of GluA2. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface GluA2 antibodies were stained ( red ), and after treatment with Triton X-100, internalized GluA2 antibodies ( green ) and the dendritic marker MAP2 were stained ( blue/white ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface GluA2-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 11–13). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student-Newman-Keuls post hoc test. D , biotinylation assay of endogenous GluA2. Hippocampal cultures were stimulated by NMDA without or with ODN2088. Cell surface proteins were biotinylated and pulled down from the total cell lysates. The amount of GluA2 proteins in the pulled down fraction ( left gel ) and total cell lysate fraction ( right gel ) were analyzed with the immunoblot analysis. NMDA stimulation decreased the amount of the cell surface GluA2, and treatment with ODN2088 blocked the NMDA effect. Right graph : the intensity of the GluA2 band in the biotinylated fraction was normalized to that of the total cell lysate fraction. The ratio of biotinylated/total GluA2 in the control cultures without ODN2088 treatment was arbitrarily set to 100% (n = 4 each). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Student-Newman-Keuls post hoc test. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; NMDA, N-methyl-d-aspartate.
    Glua2 (N Terminus) Alomone Agp 073, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-glua2+n+terminus/Guinea+pig+Anti-GluR2+(GluA2)+(extracellular)+Antibody/pmc08814153__41467_2022_28301_MOESM2_ESM-29-46-48
    Average 93 stars, based on 1 article reviews
    glua2 (n-terminus) alomone agp-073 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    glua2 n terminus  (Alomone Labs)
    93
    Alomone Labs glua2 n terminus
    a Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled for surface <t>GluA2</t> (under non-permeabilizing conditions). Graph showing the number of surface GluA2 labeling, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA, F (2, 15) = 38.28) (Tukey’s test P control-NMDAR < 0.0001, P control-mGluR < 0.0001, P NMDAR-mGluR = 0.8438). b Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled with an antibody against endogenous LC3 (autophagic structures) and MAP2 (dendrites). Graph showing the number of dendritic LC3-positive puncta in secondary dendrites, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F2,24) = 15.11, P < 0.0001) (Tukey’s test Pcontrol-NMDA = 0.0005, P control-mGluR = 0.0001). c Same as in b , but neurons were pretreated for 1 h before, during and after the pulse with wortmannin (500 nM) or SBI-0206965 (500 nM). Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions (U: untreated, W: wortmannin, S: SBI-0206965). Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(8,45) = 33.83, P < 0.0001) (Tukey’s test P control/S-NMDA/S = 0.3677, P control/W-NMDA/W = 0.9986, P NMDA/U-NMDA/W < 0.0001, P NMDA/U-NMDA/S < 0.0001, P control/S-DHPG/S = 0.9674, P control/W-DHPG/W = 0.9989, P DHPG/U-DHPG/W < 0.0001, P DHPG/U-DHPG/S < 0.0001). d Same as in b with neurons that were infected with AAV plasmids carrying 4 shRNA sequences against atg5 ( sh-atg5 ) or scrambled control ( sh-scramble ), under the CamK2a promoter. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(5,30) = 16.94, P < 0.0001) (Tukey’s test P control/scr-control/atg5 = 0.9999, P NMDA/scr-NMDA/atg5 = 0.0025, P DHPG/scr-DHPG/atg5 < 0.0001, P control/scr-NMDA/scr < 0.0001, P control/scr-DGPG/scr < 0.0001, P control/atg5-NMDA/atg5 = 0.8959, P control/atg5-DHPG/atg5 = 0.9637). e Same as in b , but neurons were immunolabeled 15 min after NMDAR- and mGluR-LTD and treated for 1 h before, during and after the pulse with Ifenprodil (10 μM) or MTEP (10 μM) and JNJ16259685 (10 μM) to pharmacologically inhibit NR2B and mGluR1/5 receptors, respectively. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F (3,32) = 74.46, P < 0.0001) (Tukey’s test, P NMDA-NMDA+IFE < 0.0001, P DHPG-DHPG+MTEP/JNJ < 0.0001). Scale bars: 10 μm for all panels.
    Glua2 N Terminus, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-glua2+n+terminus/Guinea+pig+Anti-GluR2+(GluA2)+(extracellular)+Antibody/pmc08814153-31-0-3
    Average 93 stars, based on 1 article reviews
    glua2 n terminus - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    anti-glua2 n terminus antibody  (Millipore)
    90
    Millipore anti-glua2 n terminus antibody
    a Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled for surface <t>GluA2</t> (under non-permeabilizing conditions). Graph showing the number of surface GluA2 labeling, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA, F (2, 15) = 38.28) (Tukey’s test P control-NMDAR < 0.0001, P control-mGluR < 0.0001, P NMDAR-mGluR = 0.8438). b Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled with an antibody against endogenous LC3 (autophagic structures) and MAP2 (dendrites). Graph showing the number of dendritic LC3-positive puncta in secondary dendrites, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F2,24) = 15.11, P < 0.0001) (Tukey’s test Pcontrol-NMDA = 0.0005, P control-mGluR = 0.0001). c Same as in b , but neurons were pretreated for 1 h before, during and after the pulse with wortmannin (500 nM) or SBI-0206965 (500 nM). Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions (U: untreated, W: wortmannin, S: SBI-0206965). Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(8,45) = 33.83, P < 0.0001) (Tukey’s test P control/S-NMDA/S = 0.3677, P control/W-NMDA/W = 0.9986, P NMDA/U-NMDA/W < 0.0001, P NMDA/U-NMDA/S < 0.0001, P control/S-DHPG/S = 0.9674, P control/W-DHPG/W = 0.9989, P DHPG/U-DHPG/W < 0.0001, P DHPG/U-DHPG/S < 0.0001). d Same as in b with neurons that were infected with AAV plasmids carrying 4 shRNA sequences against atg5 ( sh-atg5 ) or scrambled control ( sh-scramble ), under the CamK2a promoter. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(5,30) = 16.94, P < 0.0001) (Tukey’s test P control/scr-control/atg5 = 0.9999, P NMDA/scr-NMDA/atg5 = 0.0025, P DHPG/scr-DHPG/atg5 < 0.0001, P control/scr-NMDA/scr < 0.0001, P control/scr-DGPG/scr < 0.0001, P control/atg5-NMDA/atg5 = 0.8959, P control/atg5-DHPG/atg5 = 0.9637). e Same as in b , but neurons were immunolabeled 15 min after NMDAR- and mGluR-LTD and treated for 1 h before, during and after the pulse with Ifenprodil (10 μM) or MTEP (10 μM) and JNJ16259685 (10 μM) to pharmacologically inhibit NR2B and mGluR1/5 receptors, respectively. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F (3,32) = 74.46, P < 0.0001) (Tukey’s test, P NMDA-NMDA+IFE < 0.0001, P DHPG-DHPG+MTEP/JNJ < 0.0001). Scale bars: 10 μm for all panels.
    Anti Glua2 N Terminus Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-glua2+n+terminus/glua1+antibody/pmc04763724-482-16-21
    Average 90 stars, based on 1 article reviews
    anti-glua2 n terminus antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    anti-glua2 n-terminus monoclonal antibody  (Millipore)
    90
    Millipore anti-glua2 n-terminus monoclonal antibody
    a Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled for surface <t>GluA2</t> (under non-permeabilizing conditions). Graph showing the number of surface GluA2 labeling, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA, F (2, 15) = 38.28) (Tukey’s test P control-NMDAR < 0.0001, P control-mGluR < 0.0001, P NMDAR-mGluR = 0.8438). b Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled with an antibody against endogenous LC3 (autophagic structures) and MAP2 (dendrites). Graph showing the number of dendritic LC3-positive puncta in secondary dendrites, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F2,24) = 15.11, P < 0.0001) (Tukey’s test Pcontrol-NMDA = 0.0005, P control-mGluR = 0.0001). c Same as in b , but neurons were pretreated for 1 h before, during and after the pulse with wortmannin (500 nM) or SBI-0206965 (500 nM). Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions (U: untreated, W: wortmannin, S: SBI-0206965). Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(8,45) = 33.83, P < 0.0001) (Tukey’s test P control/S-NMDA/S = 0.3677, P control/W-NMDA/W = 0.9986, P NMDA/U-NMDA/W < 0.0001, P NMDA/U-NMDA/S < 0.0001, P control/S-DHPG/S = 0.9674, P control/W-DHPG/W = 0.9989, P DHPG/U-DHPG/W < 0.0001, P DHPG/U-DHPG/S < 0.0001). d Same as in b with neurons that were infected with AAV plasmids carrying 4 shRNA sequences against atg5 ( sh-atg5 ) or scrambled control ( sh-scramble ), under the CamK2a promoter. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(5,30) = 16.94, P < 0.0001) (Tukey’s test P control/scr-control/atg5 = 0.9999, P NMDA/scr-NMDA/atg5 = 0.0025, P DHPG/scr-DHPG/atg5 < 0.0001, P control/scr-NMDA/scr < 0.0001, P control/scr-DGPG/scr < 0.0001, P control/atg5-NMDA/atg5 = 0.8959, P control/atg5-DHPG/atg5 = 0.9637). e Same as in b , but neurons were immunolabeled 15 min after NMDAR- and mGluR-LTD and treated for 1 h before, during and after the pulse with Ifenprodil (10 μM) or MTEP (10 μM) and JNJ16259685 (10 μM) to pharmacologically inhibit NR2B and mGluR1/5 receptors, respectively. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F (3,32) = 74.46, P < 0.0001) (Tukey’s test, P NMDA-NMDA+IFE < 0.0001, P DHPG-DHPG+MTEP/JNJ < 0.0001). Scale bars: 10 μm for all panels.
    Anti Glua2 N Terminus Monoclonal Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-glua2+n+terminus/glua2+antibody/pmc04535760-44-25-29
    Average 90 stars, based on 1 article reviews
    anti-glua2 n-terminus monoclonal antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A , B ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( A ) and GluA2 ( B ) from WT primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, * P = 0.0192 for surface level, P = 0.42 for total level, and n = 17 and 18 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, ** P = 0.0025 for surface level, P = 0.1584 for total level, and n = 16 and 20 cells from two independent cultures treated with Scr and Aβ42, respectively. ( C , D ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( C ) and GluA2 ( D ) from PSD-95 +/− primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, P = 0.4539 for surface level, P = 0.1311 for total level, and n = 14 and 13 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, P = 0.6643 for surface level, P = 0.659 for total level, and n = 13 and 14 cells from two independent cultures treated with Scr and Aβ42, respectively. Data Information: significance was determined by Student’s t test ( A , C ) or Mann–Whitney U test ( B , D ). Data are represented as mean ± SEM with * P < 0.05, ** P < 0.01, ns non-significant. Scale bar: 5 μm. .

    Journal: EMBO Reports

    Article Title: Hyperfunction of post-synaptic density protein 95 promotes seizure response in early-stage aβ pathology

    doi: 10.1038/s44319-024-00090-0

    Figure Lengend Snippet: ( A , B ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( A ) and GluA2 ( B ) from WT primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, * P = 0.0192 for surface level, P = 0.42 for total level, and n = 17 and 18 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, ** P = 0.0025 for surface level, P = 0.1584 for total level, and n = 16 and 20 cells from two independent cultures treated with Scr and Aβ42, respectively. ( C , D ) Immunocytochemistry and quantification showing dendritic marker MAP2, total (t) and surface (s) GluA1 ( C ) and GluA2 ( D ) from PSD-95 +/− primary cortical neuron cultures treated with Aβ 1-42 (Aβ42, 1 µM) or scrambled peptide (Scr, 1 µM) for 2 h at DIV 12–14. For GluA1, P = 0.4539 for surface level, P = 0.1311 for total level, and n = 14 and 13 cells from two independent cultures treated with Scr and Aβ42, respectively. For GluA2, P = 0.6643 for surface level, P = 0.659 for total level, and n = 13 and 14 cells from two independent cultures treated with Scr and Aβ42, respectively. Data Information: significance was determined by Student’s t test ( A , C ) or Mann–Whitney U test ( B , D ). Data are represented as mean ± SEM with * P < 0.05, ** P < 0.01, ns non-significant. Scale bar: 5 μm. .

    Article Snippet: Mouse anti-GluA1-N-terminus antibody (#MAB2263) and mouse anti-GluA2-N-terminus antibody (#MAB397) are from Millipore.

    Techniques: Immunocytochemistry, Marker, MANN-WHITNEY

    ODN2088 blocks NMDA-induced internalization of GluA2 containing AMPA receptors. A , immunocytochemical analysis of the effects of ODN2088 on the NMDA-induced reduction of cell surface GluA2. Cultured hippocampal neurons expressing hemagglutinin (HA)-tagged GluA2 were treated with 50 μM NMDA for 10 min without or with ODN2088 (1 μM, 10 min). After fixation, cell surface HA-GluA2 were stained ( red ) and after treatment with Triton X-100, neurons were immunostained for total HA-GluA2 ( blue ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced reduction in the ratio of surface to total HA-GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity to total HA-GluA2 immunoreactivity. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 22). Data are presented as mean + SEMs and individual data points. p value by one-way ANOVA, followed by Student-Newman-Keuls post hoc test. B and C , antibody-feeding assay evaluating the effects of ODN2088 on NMDA-induced internalization of cell surface HA-GluA2 ( B ) and endogenous GluA2 ( C ). B , living neurons expressing exogenous HA-GluA2 were labeled with anti-HA antibodies. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface HA antibodies were stained ( red ), and after treatment with Triton X-100, internalized HA antibodies were stained ( green ). The dendritic regions marked by squares are magnified in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface HA-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 14). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student−Newman−Keuls post hoc test. C , endogenous GluA2 in living neurons was labeled with antibodies against the extracellular region of GluA2. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface GluA2 antibodies were stained ( red ), and after treatment with Triton X-100, internalized GluA2 antibodies ( green ) and the dendritic marker MAP2 were stained ( blue/white ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface GluA2-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 11–13). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student-Newman-Keuls post hoc test. D , biotinylation assay of endogenous GluA2. Hippocampal cultures were stimulated by NMDA without or with ODN2088. Cell surface proteins were biotinylated and pulled down from the total cell lysates. The amount of GluA2 proteins in the pulled down fraction ( left gel ) and total cell lysate fraction ( right gel ) were analyzed with the immunoblot analysis. NMDA stimulation decreased the amount of the cell surface GluA2, and treatment with ODN2088 blocked the NMDA effect. Right graph : the intensity of the GluA2 band in the biotinylated fraction was normalized to that of the total cell lysate fraction. The ratio of biotinylated/total GluA2 in the control cultures without ODN2088 treatment was arbitrarily set to 100% (n = 4 each). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Student-Newman-Keuls post hoc test. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; NMDA, N-methyl-d-aspartate.

    Journal: The Journal of Biological Chemistry

    Article Title: Activation of innate immune receptor TLR9 by mitochondrial DNA plays essential roles in the chemical long-term depression of hippocampal neurons

    doi: 10.1016/j.jbc.2024.105744

    Figure Lengend Snippet: ODN2088 blocks NMDA-induced internalization of GluA2 containing AMPA receptors. A , immunocytochemical analysis of the effects of ODN2088 on the NMDA-induced reduction of cell surface GluA2. Cultured hippocampal neurons expressing hemagglutinin (HA)-tagged GluA2 were treated with 50 μM NMDA for 10 min without or with ODN2088 (1 μM, 10 min). After fixation, cell surface HA-GluA2 were stained ( red ) and after treatment with Triton X-100, neurons were immunostained for total HA-GluA2 ( blue ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced reduction in the ratio of surface to total HA-GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity to total HA-GluA2 immunoreactivity. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 22). Data are presented as mean + SEMs and individual data points. p value by one-way ANOVA, followed by Student-Newman-Keuls post hoc test. B and C , antibody-feeding assay evaluating the effects of ODN2088 on NMDA-induced internalization of cell surface HA-GluA2 ( B ) and endogenous GluA2 ( C ). B , living neurons expressing exogenous HA-GluA2 were labeled with anti-HA antibodies. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface HA antibodies were stained ( red ), and after treatment with Triton X-100, internalized HA antibodies were stained ( green ). The dendritic regions marked by squares are magnified in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface HA-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 14). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student−Newman−Keuls post hoc test. C , endogenous GluA2 in living neurons was labeled with antibodies against the extracellular region of GluA2. Neurons were treated with 50 μM NMDA for 10 min with or without ODN2088 treatment. After fixation, cell surface GluA2 antibodies were stained ( red ), and after treatment with Triton X-100, internalized GluA2 antibodies ( green ) and the dendritic marker MAP2 were stained ( blue/white ). The dendritic regions marked by squares are enlarged in the panels to the right . The scale bar represents 10 μm. Lower graph : quantification of the NMDA-induced increase in the ratio of internalized to surface GluA2-antibody fluorescence intensities. The ratio of control neurons without ODN2088 treatment was defined as 100% (n = 11–13). Data are presented as mean + SEM and individual data points. p value by one-way ANOVA followed by Student-Newman-Keuls post hoc test. D , biotinylation assay of endogenous GluA2. Hippocampal cultures were stimulated by NMDA without or with ODN2088. Cell surface proteins were biotinylated and pulled down from the total cell lysates. The amount of GluA2 proteins in the pulled down fraction ( left gel ) and total cell lysate fraction ( right gel ) were analyzed with the immunoblot analysis. NMDA stimulation decreased the amount of the cell surface GluA2, and treatment with ODN2088 blocked the NMDA effect. Right graph : the intensity of the GluA2 band in the biotinylated fraction was normalized to that of the total cell lysate fraction. The ratio of biotinylated/total GluA2 in the control cultures without ODN2088 treatment was arbitrarily set to 100% (n = 4 each). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Student-Newman-Keuls post hoc test. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; NMDA, N-methyl-d-aspartate.

    Article Snippet: Commercial antibodies: anti-HA, (Covance 901501), anti-actin (Sigma-Aldrich A3853), anti-GluA2 N terminus (Millipore MAB397), anti-GluA2 C terminus (Millipore AB10529), anti-FLAG (Sigma F7425), anti-caspase-3 (ProteinTech 66470-2-Ig), anti-TLR9 (Abcam ab134368), anti-cytochrome c ProteinTech 10993-1-AP), anti-TOM20 (ProteinTech 11802-1-AP) and anti-DNA (Millipore CBL186) antibodies; Alexa-350 (Thermo Fisher Scientific A-11045), 405 (Thermo Fisher Scientific A-31556), 488 (Thermo Fisher Scientific A-11008), 546 (Thermo Fisher Scientific A-11003), horseradish peroxidase (Rockland 18-8816-33, 18-8817-33)-conjugated secondary antibodies.

    Techniques: Cell Culture, Expressing, Staining, Fluorescence, Feeding Assay, Labeling, Marker, Cell Surface Biotinylation Assay, Western Blot

    TLRs function on NMDA-induced reduction of cell surface GluA2. A and B , immunocytochemical analysis of the effects of TLR3 knockdown ( A ) and TLR7 knockdown ( B ) on the NMDA-induced endocytosis of cell surface GluA2. Cultured hippocampal neurons expressing HA-tagged GluA2 with siRNA were treated with 50 μM NMDA for 10 min. Following fixation, the cell surface HA-GluA2 ( red ) and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bar represents 10 μm. Right graph : quantification of NMDA-induced reduction in the ratio of surface to total HA-GluA2 fluorescence intensity. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio of control neurons was defined as 100% (n = 14). Data are presented as mean + SEM and individual data points. p value by two-tailed Student’s t test. C , immunocytochemical analysis of the effects of TLR9 knockdown on the NMDA-induced endocytosis of cell surface GluA2. Cultured hippocampal neurons expressing HA-tagged GluA2 with scrambled RNA ( top ), siRNA ( middle ), and siRNA with TLR9 resistant -FL ( bottom ) were treated with 50 μM NMDA for 10 min. Following fixation, the cell surface HA-GluA2 ( red ), TLR9 resistant -FL ( green ), and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bar represents 10 μm. Right graph : quantification of NMDA-induced reduction in the ratio of surface to total GluA2 fluorescence intensity. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio of scramble RNA transfected control neurons was defined as 100% (n = 18–21). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Dunn’s post hoc test. HA, hemagglutinin; TLR, toll-like receptor; NMDA, N-methyl-d-aspartate.

    Journal: The Journal of Biological Chemistry

    Article Title: Activation of innate immune receptor TLR9 by mitochondrial DNA plays essential roles in the chemical long-term depression of hippocampal neurons

    doi: 10.1016/j.jbc.2024.105744

    Figure Lengend Snippet: TLRs function on NMDA-induced reduction of cell surface GluA2. A and B , immunocytochemical analysis of the effects of TLR3 knockdown ( A ) and TLR7 knockdown ( B ) on the NMDA-induced endocytosis of cell surface GluA2. Cultured hippocampal neurons expressing HA-tagged GluA2 with siRNA were treated with 50 μM NMDA for 10 min. Following fixation, the cell surface HA-GluA2 ( red ) and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bar represents 10 μm. Right graph : quantification of NMDA-induced reduction in the ratio of surface to total HA-GluA2 fluorescence intensity. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio of control neurons was defined as 100% (n = 14). Data are presented as mean + SEM and individual data points. p value by two-tailed Student’s t test. C , immunocytochemical analysis of the effects of TLR9 knockdown on the NMDA-induced endocytosis of cell surface GluA2. Cultured hippocampal neurons expressing HA-tagged GluA2 with scrambled RNA ( top ), siRNA ( middle ), and siRNA with TLR9 resistant -FL ( bottom ) were treated with 50 μM NMDA for 10 min. Following fixation, the cell surface HA-GluA2 ( red ), TLR9 resistant -FL ( green ), and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bar represents 10 μm. Right graph : quantification of NMDA-induced reduction in the ratio of surface to total GluA2 fluorescence intensity. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio of scramble RNA transfected control neurons was defined as 100% (n = 18–21). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Dunn’s post hoc test. HA, hemagglutinin; TLR, toll-like receptor; NMDA, N-methyl-d-aspartate.

    Article Snippet: Commercial antibodies: anti-HA, (Covance 901501), anti-actin (Sigma-Aldrich A3853), anti-GluA2 N terminus (Millipore MAB397), anti-GluA2 C terminus (Millipore AB10529), anti-FLAG (Sigma F7425), anti-caspase-3 (ProteinTech 66470-2-Ig), anti-TLR9 (Abcam ab134368), anti-cytochrome c ProteinTech 10993-1-AP), anti-TOM20 (ProteinTech 11802-1-AP) and anti-DNA (Millipore CBL186) antibodies; Alexa-350 (Thermo Fisher Scientific A-11045), 405 (Thermo Fisher Scientific A-31556), 488 (Thermo Fisher Scientific A-11008), 546 (Thermo Fisher Scientific A-11003), horseradish peroxidase (Rockland 18-8816-33, 18-8817-33)-conjugated secondary antibodies.

    Techniques: Cell Culture, Expressing, Staining, Fluorescence, Two Tailed Test, Transfection

    Mitochondrial morphological changes and mitophagy induced by NMDA treatment. A , cultured hippocampal neurons expressing mitochondria-targeted cyan fluorescent protein (mito-CFP) were stimulated with NMDA and observed for up to 7 min. Images of the mitochondria every 1 min after NMDA stimulation from the ODN2088 untreated neuron ( upper panel ) and ODN2088 treated neuron ( lower panel ). The scale bar represents 10 μm. B , quantitative analysis of the length of mitochondria. Cultured hippocampal neurons expressing mito-CFP were stimulated with NMDA for 7 min in the absence or presence of ODN2088. After fixation, the length of mitochondria was quantified. n = 37 to 50 mitochondria from three independent cultures. Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Dunn’s post hoc test. C , histogram of mitochondrial length in the ODN2088 untreated neurons. White and black bars indicate the frequency of mitochondria without (control) or with the NMDA stimulation, respectively. D , schematic drawing of lipidation and translocation of microtubule-associated protein 1 light chain 3 (LC3) from the cytosol to the isolation membrane upon autophagy induction. Phosphatidylethanolamine is attached to cytosolic LC3 by the Atg16L complex and lipidated LC3 translocates to the isolation membrane of the autophagosome ( , ). E , cultured hippocampal neurons expressing mito-CFP and mCherry-LC3B were stimulated with NMDA and observed for up to 7 min. Images of the neurons before and 7 min after NMDA stimulation are shown. The dendritic regions enclosed by the white squares are magnified in the right panels . The scale bars represent 10 μm in the left panels and 5 μm in the right panels . Arrows indicate the mitochondria surrounded by mCherry-LC3B. Arrowheads indicate mitochondria outside autophagosomes. F , high-resolution images of mCherry-LC3 and mito-CFP from the NMDA-untreated (control) and NMDA-stimulated neurons. The scale bars represent 5 μm. G , line scan of the fluorescence intensities of mCherry-LC3 and mito-CFP. The mCherry-LC3 ( red ) and mito-CFP ( cyan ) fluorescence were quantified along the dendrites indicated by white arrows in (F), indicating that the mito-CFP signal was surrounded by the mCherry-LC3 signal in the NMDA-stimulated neuron, whereas, mCherry-LC3 uniformly distributed along the dendrite in the control neuron. H , quantitative analysis of the number of mitophagy within the 100 μm dendrite. Data are presented as mean + SEM and individual data points. n = 18 from three independent cultures. p value by two-tailed Student’s t test. I , cultured hippocampal neurons expressing HA-GluA2 were pretreated with Mdivi-1 and stimulated with NMDA. The cell surface HA-GluA2 ( red ) and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bars represent 10 μm. Right graph : quantification of NMDA-induced reduction in the ratio of the surface to total GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio in Mdivi-1–untreated control neurons was defined as 100% (n = 14–15). Data are presented as mean + SEM and individual data points. ∗ p < 0.05 by one-way ANOVA and Student-Newman-Keuls post hoc test. HA, hemagglutinin; Mdivi, mitochondrial division inhibitor; NMDA, N-methyl-d-aspartate.

    Journal: The Journal of Biological Chemistry

    Article Title: Activation of innate immune receptor TLR9 by mitochondrial DNA plays essential roles in the chemical long-term depression of hippocampal neurons

    doi: 10.1016/j.jbc.2024.105744

    Figure Lengend Snippet: Mitochondrial morphological changes and mitophagy induced by NMDA treatment. A , cultured hippocampal neurons expressing mitochondria-targeted cyan fluorescent protein (mito-CFP) were stimulated with NMDA and observed for up to 7 min. Images of the mitochondria every 1 min after NMDA stimulation from the ODN2088 untreated neuron ( upper panel ) and ODN2088 treated neuron ( lower panel ). The scale bar represents 10 μm. B , quantitative analysis of the length of mitochondria. Cultured hippocampal neurons expressing mito-CFP were stimulated with NMDA for 7 min in the absence or presence of ODN2088. After fixation, the length of mitochondria was quantified. n = 37 to 50 mitochondria from three independent cultures. Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Dunn’s post hoc test. C , histogram of mitochondrial length in the ODN2088 untreated neurons. White and black bars indicate the frequency of mitochondria without (control) or with the NMDA stimulation, respectively. D , schematic drawing of lipidation and translocation of microtubule-associated protein 1 light chain 3 (LC3) from the cytosol to the isolation membrane upon autophagy induction. Phosphatidylethanolamine is attached to cytosolic LC3 by the Atg16L complex and lipidated LC3 translocates to the isolation membrane of the autophagosome ( , ). E , cultured hippocampal neurons expressing mito-CFP and mCherry-LC3B were stimulated with NMDA and observed for up to 7 min. Images of the neurons before and 7 min after NMDA stimulation are shown. The dendritic regions enclosed by the white squares are magnified in the right panels . The scale bars represent 10 μm in the left panels and 5 μm in the right panels . Arrows indicate the mitochondria surrounded by mCherry-LC3B. Arrowheads indicate mitochondria outside autophagosomes. F , high-resolution images of mCherry-LC3 and mito-CFP from the NMDA-untreated (control) and NMDA-stimulated neurons. The scale bars represent 5 μm. G , line scan of the fluorescence intensities of mCherry-LC3 and mito-CFP. The mCherry-LC3 ( red ) and mito-CFP ( cyan ) fluorescence were quantified along the dendrites indicated by white arrows in (F), indicating that the mito-CFP signal was surrounded by the mCherry-LC3 signal in the NMDA-stimulated neuron, whereas, mCherry-LC3 uniformly distributed along the dendrite in the control neuron. H , quantitative analysis of the number of mitophagy within the 100 μm dendrite. Data are presented as mean + SEM and individual data points. n = 18 from three independent cultures. p value by two-tailed Student’s t test. I , cultured hippocampal neurons expressing HA-GluA2 were pretreated with Mdivi-1 and stimulated with NMDA. The cell surface HA-GluA2 ( red ) and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bars represent 10 μm. Right graph : quantification of NMDA-induced reduction in the ratio of the surface to total GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio in Mdivi-1–untreated control neurons was defined as 100% (n = 14–15). Data are presented as mean + SEM and individual data points. ∗ p < 0.05 by one-way ANOVA and Student-Newman-Keuls post hoc test. HA, hemagglutinin; Mdivi, mitochondrial division inhibitor; NMDA, N-methyl-d-aspartate.

    Article Snippet: Commercial antibodies: anti-HA, (Covance 901501), anti-actin (Sigma-Aldrich A3853), anti-GluA2 N terminus (Millipore MAB397), anti-GluA2 C terminus (Millipore AB10529), anti-FLAG (Sigma F7425), anti-caspase-3 (ProteinTech 66470-2-Ig), anti-TLR9 (Abcam ab134368), anti-cytochrome c ProteinTech 10993-1-AP), anti-TOM20 (ProteinTech 11802-1-AP) and anti-DNA (Millipore CBL186) antibodies; Alexa-350 (Thermo Fisher Scientific A-11045), 405 (Thermo Fisher Scientific A-31556), 488 (Thermo Fisher Scientific A-11008), 546 (Thermo Fisher Scientific A-11003), horseradish peroxidase (Rockland 18-8816-33, 18-8817-33)-conjugated secondary antibodies.

    Techniques: Cell Culture, Expressing, Translocation Assay, Isolation, Membrane, Fluorescence, Two Tailed Test, Staining

    Mitochondrial DNA amount affected the NMDA-induced internalization of AMPA receptors. A , dideoxycytidine (ddC) reduced the amount of mitochondrial DNA (mtDNA). Cultured hippocampal neurons were treated with ddC for 96 h and stained by the antiMAP2 and DNA antibodies. The fluorescence intensities of DNA staining within the dendrites were quantified. The average fluorescence intensities of ddC untreated (control) neurons were defined as 100% (n = 16). Data are presented as mean + SEM and individual data points. p value by two-tailed Student’s t test. The scale bars represent 10 μm. B , cultured hippocampal neurons expressing HA-GluA2 were pretreated with ddC and stimulated with NMDA. The cell surface HA-GluA2 ( red ) and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bars represent 10 μm. Lower graph : quantification of NMDA-induced reduction in the ratio of the surface to total GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio in ddC-untreated control neurons was defined as 100% (n = 15). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Student-Newman-Keuls post hoc test. C , ddC effects on the NMDA-induced AMPA receptor endocytosis in the TLR9 knocked down neurons. The ratio in ddC-untreated control neurons was defined as 100% (n = 16). Data are presented as mean + SEM and individual data points. No significant difference was detected by one-way ANOVA. The scale bars represent 10 μm. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; HA, hemagglutinin; NMDA, N-methyl-d-aspartate; TLR, toll-like receptor.

    Journal: The Journal of Biological Chemistry

    Article Title: Activation of innate immune receptor TLR9 by mitochondrial DNA plays essential roles in the chemical long-term depression of hippocampal neurons

    doi: 10.1016/j.jbc.2024.105744

    Figure Lengend Snippet: Mitochondrial DNA amount affected the NMDA-induced internalization of AMPA receptors. A , dideoxycytidine (ddC) reduced the amount of mitochondrial DNA (mtDNA). Cultured hippocampal neurons were treated with ddC for 96 h and stained by the antiMAP2 and DNA antibodies. The fluorescence intensities of DNA staining within the dendrites were quantified. The average fluorescence intensities of ddC untreated (control) neurons were defined as 100% (n = 16). Data are presented as mean + SEM and individual data points. p value by two-tailed Student’s t test. The scale bars represent 10 μm. B , cultured hippocampal neurons expressing HA-GluA2 were pretreated with ddC and stimulated with NMDA. The cell surface HA-GluA2 ( red ) and total HA-GluA2 ( blue ) were stained. The dendritic regions marked by squares were enlarged in the panels to the right . The scale bars represent 10 μm. Lower graph : quantification of NMDA-induced reduction in the ratio of the surface to total GluA2 fluorescence intensities. Data are represented as the ratio of surface HA-GluA2 immunoreactivity normalized by total HA-GluA2 immunoreactivity. The ratio in ddC-untreated control neurons was defined as 100% (n = 15). Data are presented as mean + SEM and individual data points. p value by Kruskal–Wallis test and Student-Newman-Keuls post hoc test. C , ddC effects on the NMDA-induced AMPA receptor endocytosis in the TLR9 knocked down neurons. The ratio in ddC-untreated control neurons was defined as 100% (n = 16). Data are presented as mean + SEM and individual data points. No significant difference was detected by one-way ANOVA. The scale bars represent 10 μm. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; HA, hemagglutinin; NMDA, N-methyl-d-aspartate; TLR, toll-like receptor.

    Article Snippet: Commercial antibodies: anti-HA, (Covance 901501), anti-actin (Sigma-Aldrich A3853), anti-GluA2 N terminus (Millipore MAB397), anti-GluA2 C terminus (Millipore AB10529), anti-FLAG (Sigma F7425), anti-caspase-3 (ProteinTech 66470-2-Ig), anti-TLR9 (Abcam ab134368), anti-cytochrome c ProteinTech 10993-1-AP), anti-TOM20 (ProteinTech 11802-1-AP) and anti-DNA (Millipore CBL186) antibodies; Alexa-350 (Thermo Fisher Scientific A-11045), 405 (Thermo Fisher Scientific A-31556), 488 (Thermo Fisher Scientific A-11008), 546 (Thermo Fisher Scientific A-11003), horseradish peroxidase (Rockland 18-8816-33, 18-8817-33)-conjugated secondary antibodies.

    Techniques: Cell Culture, Staining, Fluorescence, Two Tailed Test, Expressing

    a Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled for surface GluA2 (under non-permeabilizing conditions). Graph showing the number of surface GluA2 labeling, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA, F (2, 15) = 38.28) (Tukey’s test P control-NMDAR < 0.0001, P control-mGluR < 0.0001, P NMDAR-mGluR = 0.8438). b Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled with an antibody against endogenous LC3 (autophagic structures) and MAP2 (dendrites). Graph showing the number of dendritic LC3-positive puncta in secondary dendrites, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F2,24) = 15.11, P < 0.0001) (Tukey’s test Pcontrol-NMDA = 0.0005, P control-mGluR = 0.0001). c Same as in b , but neurons were pretreated for 1 h before, during and after the pulse with wortmannin (500 nM) or SBI-0206965 (500 nM). Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions (U: untreated, W: wortmannin, S: SBI-0206965). Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(8,45) = 33.83, P < 0.0001) (Tukey’s test P control/S-NMDA/S = 0.3677, P control/W-NMDA/W = 0.9986, P NMDA/U-NMDA/W < 0.0001, P NMDA/U-NMDA/S < 0.0001, P control/S-DHPG/S = 0.9674, P control/W-DHPG/W = 0.9989, P DHPG/U-DHPG/W < 0.0001, P DHPG/U-DHPG/S < 0.0001). d Same as in b with neurons that were infected with AAV plasmids carrying 4 shRNA sequences against atg5 ( sh-atg5 ) or scrambled control ( sh-scramble ), under the CamK2a promoter. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(5,30) = 16.94, P < 0.0001) (Tukey’s test P control/scr-control/atg5 = 0.9999, P NMDA/scr-NMDA/atg5 = 0.0025, P DHPG/scr-DHPG/atg5 < 0.0001, P control/scr-NMDA/scr < 0.0001, P control/scr-DGPG/scr < 0.0001, P control/atg5-NMDA/atg5 = 0.8959, P control/atg5-DHPG/atg5 = 0.9637). e Same as in b , but neurons were immunolabeled 15 min after NMDAR- and mGluR-LTD and treated for 1 h before, during and after the pulse with Ifenprodil (10 μM) or MTEP (10 μM) and JNJ16259685 (10 μM) to pharmacologically inhibit NR2B and mGluR1/5 receptors, respectively. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F (3,32) = 74.46, P < 0.0001) (Tukey’s test, P NMDA-NMDA+IFE < 0.0001, P DHPG-DHPG+MTEP/JNJ < 0.0001). Scale bars: 10 μm for all panels.

    Journal: Nature Communications

    Article Title: Dendritic autophagy degrades postsynaptic proteins and is required for long-term synaptic depression in mice

    doi: 10.1038/s41467-022-28301-z

    Figure Lengend Snippet: a Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled for surface GluA2 (under non-permeabilizing conditions). Graph showing the number of surface GluA2 labeling, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA, F (2, 15) = 38.28) (Tukey’s test P control-NMDAR < 0.0001, P control-mGluR < 0.0001, P NMDAR-mGluR = 0.8438). b Representative confocal images of cultured neurons under control conditions or 15 min after chemical NMDAR- or mGluR-LTD, immunolabeled with an antibody against endogenous LC3 (autophagic structures) and MAP2 (dendrites). Graph showing the number of dendritic LC3-positive puncta in secondary dendrites, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F2,24) = 15.11, P < 0.0001) (Tukey’s test Pcontrol-NMDA = 0.0005, P control-mGluR = 0.0001). c Same as in b , but neurons were pretreated for 1 h before, during and after the pulse with wortmannin (500 nM) or SBI-0206965 (500 nM). Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions (U: untreated, W: wortmannin, S: SBI-0206965). Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(8,45) = 33.83, P < 0.0001) (Tukey’s test P control/S-NMDA/S = 0.3677, P control/W-NMDA/W = 0.9986, P NMDA/U-NMDA/W < 0.0001, P NMDA/U-NMDA/S < 0.0001, P control/S-DHPG/S = 0.9674, P control/W-DHPG/W = 0.9989, P DHPG/U-DHPG/W < 0.0001, P DHPG/U-DHPG/S < 0.0001). d Same as in b with neurons that were infected with AAV plasmids carrying 4 shRNA sequences against atg5 ( sh-atg5 ) or scrambled control ( sh-scramble ), under the CamK2a promoter. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. Bars represent mean values ± SEM. N = 6 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F(5,30) = 16.94, P < 0.0001) (Tukey’s test P control/scr-control/atg5 = 0.9999, P NMDA/scr-NMDA/atg5 = 0.0025, P DHPG/scr-DHPG/atg5 < 0.0001, P control/scr-NMDA/scr < 0.0001, P control/scr-DGPG/scr < 0.0001, P control/atg5-NMDA/atg5 = 0.8959, P control/atg5-DHPG/atg5 = 0.9637). e Same as in b , but neurons were immunolabeled 15 min after NMDAR- and mGluR-LTD and treated for 1 h before, during and after the pulse with Ifenprodil (10 μM) or MTEP (10 μM) and JNJ16259685 (10 μM) to pharmacologically inhibit NR2B and mGluR1/5 receptors, respectively. Graph showing the number of dendritic LC3-positive puncta, normalized to the dendritic length, in the indicated conditions. N = 9 independent experiments per condition. Statistical analyses were performed by one-way ANOVA (F (3,32) = 74.46, P < 0.0001) (Tukey’s test, P NMDA-NMDA+IFE < 0.0001, P DHPG-DHPG+MTEP/JNJ < 0.0001). Scale bars: 10 μm for all panels.

    Article Snippet: GluA2 (N-terminus) , Alomone , AGP-073 , , 1/1000.

    Techniques: Confocal, Cell Culture, Control, Immunolabeling, Labeling, Infection, shRNA, Immunofluorescence

    a Confocal images of dendrites immunolabeled with an antibody against the extracellular region of GluA2 under control conditions or 15 min after LTD induction and in the absence or presence of Dynamin-1 inhibitory peptide (50 µM) or SBI-0206965 (500 nM), a selective inhibitor of the ULK1 kinase activity. Inhibitors were applied 25 min before, during and 15 min after the pulses. Scale bar: 10 µm. Graph showing the surface labeling of GluA2, normalized to dendritic length under the aforementioned conditions. Bars represent mean values ± SEM. N = 9 independent experiments. Statistical analysis was performed using one-way ANOVA (F (8, 72) = 7.411, P < 0.0001) (Tukey’s test P control-control/D > 0.99, P control-control/S = 0.9971, P NMDA-NMDA/D = 0.0451, P NMDA-NMDA/S = 0.0008, P DHPG-DHPG/D = 0.0017, P DHPG-DHPG/S = 0.0002). b Confocal images of dendrites of neurons expressing 4 scrambled sequences ( sh-scramble ), or 4 sh-RNAs against atg5 ( sh-atg5 ), immunolabeled with an antibody against the extracellular region of GluA2 under control conditions or 15 min after LTD induction. Graph showing the surface labeling of GluA2, normalized to dendritic length under the aforementioned conditions. Bars represent mean values ± SEM. N = 10 independent experiments. Statistical analysis was performed using one-way ANOVA (F (5, 54) = 30.02, P < 0.0001) (Tukey’s test, P control/scr-control/atg5 = 0.0626, P NMDA/scr-NMDA/atg5 < 0.0001, P DHPG/scr-DHPG/atg5 < 0.0001, P control/atg5-NMDA/atg5 > 0.99, P control/atg5-DHPG/atg5 = 0.8602, P control/scr-NMDA/scr = 0.0008, P control/scr-DHPG/scr < 0.0001). c Representative images of consecutive confocal z-planes of cultured neurons immunostained with antibodies against PSD95, LC3, and MAP2 to label the dendrites, 15 min after cLTD. Note the colocalization of PSD95 and LC3 in dendritic spines (yellow arrows) and in the dendritic shaft (white arrows), in consecutive z-planes. Scale bar: 10 µm. Graph showing the percentage of PSD95 puncta co-localizing with LC3 in consecutive confocal z-planes in dendritic spines and shafts in control neurons or 15 min after chemically induced NMDAR- or mGluR-LTD. Bars represent mean values ± SEM. N = 8 independent experiments. Statistical analysis was performed by one-way ANOVA (F(5,42) = 48.43, P < 0.0001) (Tukey’s test for dendritic shaft, P control-NMDA = 0.0569, P control-DHPG = 0.1948, for dendritic spines, P control-NMDA < 0.0001, P control-DHPG < 0.0001). d Western blot analysis for GluA2 and PSD95 in lysates of cultured neurons in control conditions or 15 min after NMDAR- and mGluR-LTD and in the presence or absence of Bafilomycin A1 (50 µM) for 15 min before, during, and 15 min after the NMDA and DHPG pulses. e Western blot analysis for GluA2 and PSD95 in lysates of cultured neurons in control conditions or 15 min after NMDAR- and mGluR-LTD and in the presence or absence of SBI-0206965 (500 nM) for 30 min before, during, and 15 min after the NMDA and DHPG pulses. f Western blot analysis for GluA2 and PSD95 in lysates of cultured shscrambled or sh-atg5 expressing neurons in control conditions or 15 min after NMDAR- and mGluR-LTD. d – f Graphs showing the levels of PSD95 and GluA2 levels in the indicated conditions, normalized to total protein levels. Bars represent mean values ± SEM. Statistical analysis was performed by one-way ANOVA. d (N = 9 independent experiments) PSD95: F(5,48) = 15.08, P < 0.0001 (Tukey’s test P control-control/Baf = 0.7566, P control-NMDA = 0.0016, P control-DHPG = 0.0081, P NMDA-NMDA/Baf < 0.0001, P DHPG-DHPG/Baf = 0.0013. GluA2: F(5,48)=6.627, P < 0.0001 (Tukey’s test P control-control/Baf = 0.9692, P control-NMDA = 0.0014, P control-DHPG = 0.0067, P NMDA-NMDA/Baf = 0.0421, P DHPG-DHPG/Baf = 0.0127. e ( N = 7 independent experiments) PSD95: F(5,36) = 23.80, P < 0.0001. (Tukey’s test P control-control/SBI > 0.99, P NMDA-NMDA/SBI < 0.0001, P DHPG-DHPG/SBI < 0.0001, P control-NMDA < 0.0001, P control-DHPG < 0.0001, P control/SBI-NMDA/SBI = 0.9764, P control/SBI-DHPG/SBI = 0.6286). Panel e, GluA2: F(5,36)=11.73, P < 0.0001. (Tukey’s test P control-control/SBI = 0.9179, P NMDA-NMDA/SBI = 0.0001, P DHPG-DHPG/SBI = 0.0002, P control-NMDA = 0.0099, P control-DHPG = 0.0323, P control/SBI-NMDA/SBI = 0.9959, P control/SBI-DHPG/SBI = 0.9407). f ( N = 7 independent experiments) PSD95: F(5,36) = 10.93, P < 0.0001. (Tukey’s test P control/scr-control/atg5 = 0.7927, P NMDA/scr-NMDA/atg5 = 0.0045, P DHPG/scr-DHPG/atg5 = 0.0003, P control/scr-NMDA/scr = 0.0134, P control/scr-DHPG/scr = 0.0030, P control/atg5-NMDA/atg5 = 0.9488, P control/atg5-DHPG/atg5 = 0.9976). GluA2: F(5,36) = 10.79, P < 0.0001. (Tukey’s test P control/scr-control/atg5 > 0.99, P NMDA/scr-NMDA/atg5 = 0,0001, P DHPG/scr-DHPG/atg5 = 0.0019, P control/scr-NMDA/scr = 0.0134, P control/scr-DHPG/scr = 0.0021, P control/atg5-NMDA/atg5 = 0.5844, P control/atg5-DHPG/atg5 > 0.99).

    Journal: Nature Communications

    Article Title: Dendritic autophagy degrades postsynaptic proteins and is required for long-term synaptic depression in mice

    doi: 10.1038/s41467-022-28301-z

    Figure Lengend Snippet: a Confocal images of dendrites immunolabeled with an antibody against the extracellular region of GluA2 under control conditions or 15 min after LTD induction and in the absence or presence of Dynamin-1 inhibitory peptide (50 µM) or SBI-0206965 (500 nM), a selective inhibitor of the ULK1 kinase activity. Inhibitors were applied 25 min before, during and 15 min after the pulses. Scale bar: 10 µm. Graph showing the surface labeling of GluA2, normalized to dendritic length under the aforementioned conditions. Bars represent mean values ± SEM. N = 9 independent experiments. Statistical analysis was performed using one-way ANOVA (F (8, 72) = 7.411, P < 0.0001) (Tukey’s test P control-control/D > 0.99, P control-control/S = 0.9971, P NMDA-NMDA/D = 0.0451, P NMDA-NMDA/S = 0.0008, P DHPG-DHPG/D = 0.0017, P DHPG-DHPG/S = 0.0002). b Confocal images of dendrites of neurons expressing 4 scrambled sequences ( sh-scramble ), or 4 sh-RNAs against atg5 ( sh-atg5 ), immunolabeled with an antibody against the extracellular region of GluA2 under control conditions or 15 min after LTD induction. Graph showing the surface labeling of GluA2, normalized to dendritic length under the aforementioned conditions. Bars represent mean values ± SEM. N = 10 independent experiments. Statistical analysis was performed using one-way ANOVA (F (5, 54) = 30.02, P < 0.0001) (Tukey’s test, P control/scr-control/atg5 = 0.0626, P NMDA/scr-NMDA/atg5 < 0.0001, P DHPG/scr-DHPG/atg5 < 0.0001, P control/atg5-NMDA/atg5 > 0.99, P control/atg5-DHPG/atg5 = 0.8602, P control/scr-NMDA/scr = 0.0008, P control/scr-DHPG/scr < 0.0001). c Representative images of consecutive confocal z-planes of cultured neurons immunostained with antibodies against PSD95, LC3, and MAP2 to label the dendrites, 15 min after cLTD. Note the colocalization of PSD95 and LC3 in dendritic spines (yellow arrows) and in the dendritic shaft (white arrows), in consecutive z-planes. Scale bar: 10 µm. Graph showing the percentage of PSD95 puncta co-localizing with LC3 in consecutive confocal z-planes in dendritic spines and shafts in control neurons or 15 min after chemically induced NMDAR- or mGluR-LTD. Bars represent mean values ± SEM. N = 8 independent experiments. Statistical analysis was performed by one-way ANOVA (F(5,42) = 48.43, P < 0.0001) (Tukey’s test for dendritic shaft, P control-NMDA = 0.0569, P control-DHPG = 0.1948, for dendritic spines, P control-NMDA < 0.0001, P control-DHPG < 0.0001). d Western blot analysis for GluA2 and PSD95 in lysates of cultured neurons in control conditions or 15 min after NMDAR- and mGluR-LTD and in the presence or absence of Bafilomycin A1 (50 µM) for 15 min before, during, and 15 min after the NMDA and DHPG pulses. e Western blot analysis for GluA2 and PSD95 in lysates of cultured neurons in control conditions or 15 min after NMDAR- and mGluR-LTD and in the presence or absence of SBI-0206965 (500 nM) for 30 min before, during, and 15 min after the NMDA and DHPG pulses. f Western blot analysis for GluA2 and PSD95 in lysates of cultured shscrambled or sh-atg5 expressing neurons in control conditions or 15 min after NMDAR- and mGluR-LTD. d – f Graphs showing the levels of PSD95 and GluA2 levels in the indicated conditions, normalized to total protein levels. Bars represent mean values ± SEM. Statistical analysis was performed by one-way ANOVA. d (N = 9 independent experiments) PSD95: F(5,48) = 15.08, P < 0.0001 (Tukey’s test P control-control/Baf = 0.7566, P control-NMDA = 0.0016, P control-DHPG = 0.0081, P NMDA-NMDA/Baf < 0.0001, P DHPG-DHPG/Baf = 0.0013. GluA2: F(5,48)=6.627, P < 0.0001 (Tukey’s test P control-control/Baf = 0.9692, P control-NMDA = 0.0014, P control-DHPG = 0.0067, P NMDA-NMDA/Baf = 0.0421, P DHPG-DHPG/Baf = 0.0127. e ( N = 7 independent experiments) PSD95: F(5,36) = 23.80, P < 0.0001. (Tukey’s test P control-control/SBI > 0.99, P NMDA-NMDA/SBI < 0.0001, P DHPG-DHPG/SBI < 0.0001, P control-NMDA < 0.0001, P control-DHPG < 0.0001, P control/SBI-NMDA/SBI = 0.9764, P control/SBI-DHPG/SBI = 0.6286). Panel e, GluA2: F(5,36)=11.73, P < 0.0001. (Tukey’s test P control-control/SBI = 0.9179, P NMDA-NMDA/SBI = 0.0001, P DHPG-DHPG/SBI = 0.0002, P control-NMDA = 0.0099, P control-DHPG = 0.0323, P control/SBI-NMDA/SBI = 0.9959, P control/SBI-DHPG/SBI = 0.9407). f ( N = 7 independent experiments) PSD95: F(5,36) = 10.93, P < 0.0001. (Tukey’s test P control/scr-control/atg5 = 0.7927, P NMDA/scr-NMDA/atg5 = 0.0045, P DHPG/scr-DHPG/atg5 = 0.0003, P control/scr-NMDA/scr = 0.0134, P control/scr-DHPG/scr = 0.0030, P control/atg5-NMDA/atg5 = 0.9488, P control/atg5-DHPG/atg5 = 0.9976). GluA2: F(5,36) = 10.79, P < 0.0001. (Tukey’s test P control/scr-control/atg5 > 0.99, P NMDA/scr-NMDA/atg5 = 0,0001, P DHPG/scr-DHPG/atg5 = 0.0019, P control/scr-NMDA/scr = 0.0134, P control/scr-DHPG/scr = 0.0021, P control/atg5-NMDA/atg5 = 0.5844, P control/atg5-DHPG/atg5 > 0.99).

    Article Snippet: GluA2 (N-terminus) , Alomone , AGP-073 , , 1/1000.

    Techniques: Confocal, Immunolabeling, Control, Activity Assay, Labeling, Analysis, Expressing, Cell Culture, Western Blot, Immunofluorescence

    a – d Western blot analyses of different fractions along the autophagic vesicle purification procedure, using antibodies against a autophagosomal markers (LC3B, p62, Atg16L1, and Atg9A), b ER-Golgi markers (TGN, LMAN1, SAR1a), c endosomal markers (Rab11b, EEA1), and d markers of the plasma-membrane (Stx4), extracellular vesicles (Alix) and nuclear extracts (TBP). N = 3 independent experiments. e Graph showing the cell component analysis, as false discovery rate (FDR)-corrected p -values, of the dynamic cargo (total of 393 proteins) that is enriched (up) or less abundant (down) in AVs after LTD, compared to control. f Graphical representation of proteins enriched in AVs upon LTD, with relation to the synapse. g Western blot analysis of PK-treated control and LTD-AVs, validating the presence of the proteins identified by the proteomic analyses in the autophagic vesicles. Postsynaptic density (PSD) fraction was used as reference. Graph showing the fold change of the normalized levels of the proteins validated by western blot, as a ratio of LTD to control. Cargo proteins were normalized to the levels of p62, which remains unaffected at the early phase of LTD. N = 3 independent AV preparations. Bars represent mean values ± SEM. Statistical analysis was performed using paired, two-tailed Student’s t -test (GluA1, N = 6, P = 0.0002; GluA2, N = 6, P = 0.0039; Pick1, N = 5, P = 0.011; SAP97, N = 5, P = 0.0179; FYN, N = 8, P < 0.0001; CamKIIa, N = 8, P < 0.0001; IL1RAPL1, N = 8, P = 0.0004; Adam22, N = 4, P = 0.0018; INA, N = 3, P = 0.0287; MYH10, N = 8, P < 0.0001; ITPKA, N = 6, P = 0.0006; KCC2, N = 4, P = 0. 0352; cofilin-1, N = 6, P = 0.005; dynamin, N = 6, P = 0.0005; p62, N = 6, P = 0.9809). All indicated molecular weights in a – d and g are in kDaltons (kD).

    Journal: Nature Communications

    Article Title: Dendritic autophagy degrades postsynaptic proteins and is required for long-term synaptic depression in mice

    doi: 10.1038/s41467-022-28301-z

    Figure Lengend Snippet: a – d Western blot analyses of different fractions along the autophagic vesicle purification procedure, using antibodies against a autophagosomal markers (LC3B, p62, Atg16L1, and Atg9A), b ER-Golgi markers (TGN, LMAN1, SAR1a), c endosomal markers (Rab11b, EEA1), and d markers of the plasma-membrane (Stx4), extracellular vesicles (Alix) and nuclear extracts (TBP). N = 3 independent experiments. e Graph showing the cell component analysis, as false discovery rate (FDR)-corrected p -values, of the dynamic cargo (total of 393 proteins) that is enriched (up) or less abundant (down) in AVs after LTD, compared to control. f Graphical representation of proteins enriched in AVs upon LTD, with relation to the synapse. g Western blot analysis of PK-treated control and LTD-AVs, validating the presence of the proteins identified by the proteomic analyses in the autophagic vesicles. Postsynaptic density (PSD) fraction was used as reference. Graph showing the fold change of the normalized levels of the proteins validated by western blot, as a ratio of LTD to control. Cargo proteins were normalized to the levels of p62, which remains unaffected at the early phase of LTD. N = 3 independent AV preparations. Bars represent mean values ± SEM. Statistical analysis was performed using paired, two-tailed Student’s t -test (GluA1, N = 6, P = 0.0002; GluA2, N = 6, P = 0.0039; Pick1, N = 5, P = 0.011; SAP97, N = 5, P = 0.0179; FYN, N = 8, P < 0.0001; CamKIIa, N = 8, P < 0.0001; IL1RAPL1, N = 8, P = 0.0004; Adam22, N = 4, P = 0.0018; INA, N = 3, P = 0.0287; MYH10, N = 8, P < 0.0001; ITPKA, N = 6, P = 0.0006; KCC2, N = 4, P = 0. 0352; cofilin-1, N = 6, P = 0.005; dynamin, N = 6, P = 0.0005; p62, N = 6, P = 0.9809). All indicated molecular weights in a – d and g are in kDaltons (kD).

    Article Snippet: GluA2 (N-terminus) , Alomone , AGP-073 , , 1/1000.

    Techniques: Western Blot, Purification, Clinical Proteomics, Membrane, Analysis, Control, Two Tailed Test

    Journal: Nature Communications

    Article Title: Dendritic autophagy degrades postsynaptic proteins and is required for long-term synaptic depression in mice

    doi: 10.1038/s41467-022-28301-z

    Figure Lengend Snippet:

    Article Snippet: GluA2 (N-terminus) , Alomone , AGP-073 , , 1/1000.

    Techniques: